BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

King pharmaceuticals AND earnings call AND 2005 Pages on BioPortfolio:

BioPortfolio - King Pharmaceuticals
13th July, 2005, King Pharmaceuticals Research & Development Inc., 400 CentreGreen Way, ... Morning Call: Nov 16 2008 2:21PM Matching: king
pharmaceuticals ...
http://www.bioportfolio.com/biocorporate/6108-King_Pharmaceu...

BioPortfolio - King Pharmaceuticals - Profile
2005. Mar-Apr;12(2):166-71. BioNews Results for King Pharmaceuticals ... Alexza Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript ...
http://www.bioportfolio.com/biocorporate/6108-King+Pharmaceu...

BioPortfolio - Resolution Pharmaceuticals Incorporated
Inspire Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript, ... Bristol, Tennessee, November 1, 2005 -- King Pharmaceuticals, Inc. (NYSE:KG) announced
...
http://www.bioportfolio.com/search/Resolution_Pharmaceutical...

BioPortfolio - Louping Ill - InDepth
2005. Aug;111(2):161-74. (DOI Direct Link). • Louping ill in llamas (Lama glama) in the ... King Pharmaceuticals Inc. Q3 2008 Earnings Call Transcript ...
http://www.bioportfolio.com/indepth/Louping_Ill.pdf...

BioPortfolio - Maxim Pharmaceuticals Incorporated - Profile
A. 2005 Aug 23;102(34):12095-100. Epub 2005 Aug 15. (DOI Direct Link) .... King Pharmaceuticals Inc. Q3 2008 Earnings Call Transcript ...
http://www.bioportfolio.com/biocorporate/6698-Maxim%252BPhar...

BioPortfolio - Network Science Corporation - Profile
King Pharmaceuticals Inc. Q3 2008 Earnings Call Transcript. Seeking Alpha: Nov 7 2008 10:01AM ... Pharma Live: Nov 7 2008 2:44AM Matching: network science ...
http://www.bioportfolio.com/biocorporate/27077-Network+Scien...

BioPortfolio - Cytochromes A1 - InDepth
2005;10(2-4):223-33. (DOI Direct Link) ... 2005 Nov. 2;127(43):14964-5. (DOI Direct Link) ... King Pharmaceuticals Inc. Q3 2008 Earnings Call Transcript ...
http://www.bioportfolio.com/indepth/Cytochromes_A1.pdf...

BioPortfolio - Group III Phospholipases A2
2005 Jul 1;280(26):24987-98. Epub 2005 Apr 29. ... King Pharmaceuticals Inc. Q3 2008 Earnings Call Transcript, Seeking Alpha: Nov 7 2008 10:01AM Matching: ...
http://www.bioportfolio.com/indepth/Group_III_Phospholipases...

BioPortfolio - Group III Phospholipases A2 - InDepth
Epub 2005 Apr 29. (DOI Direct Link). • Group III secreted phospholipase A2 causes apoptosis ... King Pharmaceuticals Inc. Q3 2008 Earnings Call Transcript
...
http://www.bioportfolio.com/indepth/Group_III_Phospholipases...

BioPortfolio - Hyperlipoproteinemia Type Iii - InDepth
2005. Nov-Dec;11(6):394-8. • Apolipoprotein A5 S19W may play a role in dysbetalipoproteinemia ... King Pharmaceuticals Inc. Q3 2008 Earnings Call
Transcript ...
http://www.bioportfolio.com/indepth/Hyperlipoproteinemia_Typ...

Results from other life science and pharmaceutical sites:

King Pharmaceuticals Provides Details for Webcast of Live ...
King Pharmaceuticals Provides Details for Webcast of Live Conference Call Following Release Of Second-Quarter 2005 Earnings ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

BioPortfolio - King Pharmaceuticals
13th July, 2005, King Pharmaceuticals Research & Development Inc., 400 CentreGreen Way, ... Morning Call: Nov 16 2008 2:21PM Matching: king
pharmaceuticals ...
http://www.bioportfolio.com/biocorporate/6108-King_Pharmaceu...

King Pharmaceuticals Provides Details for Live Webcast and ...
King Pharmaceuticals Provides Details for Live Webcast and Conference Call Following Release of Fourth Quarter 2005 Earnings ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

BioPortfolio - King Pharmaceuticals - Profile
2005. Mar-Apr;12(2):166-71. BioNews Results for King Pharmaceuticals ... Alexza Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript ...
http://www.bioportfolio.com/biocorporate/6108-King+Pharmaceu...

King Pharmaceuticals Reports First-Quarter 2006 Financial Results
KING PHARMACEUTICALS, INC. CONSOLIDATED BALANCE SHEETS (in thousands, except share data) March 31, December 31, 2006 2005 (Unaudited) ASSETS Current assets:
...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

King Pharmaceuticals, Inc
BRISTOL, TENNESSEE, May 3, 2005 - King Pharmaceuticals, Inc. (NYSE:KG) ... a result of these developments, King estimates that diluted earnings per share ...
http://www.kingpharm.com/kingpharm/uploads/pdf_news/05-03-20...

King Pharmaceuticals To Webcast Live Conference Call Following ...
King Pharmaceuticals To Webcast Live Conference Call Following Release of ... As previously announced, King plans to announce earnings for the first quarter ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

BioPortfolio - Louping Ill - InDepth
2005. Aug;111(2):161-74. (DOI Direct Link). • Louping ill in llamas (Lama glama) in the ... King Pharmaceuticals Inc. Q3 2008 Earnings Call Transcript ...
http://www.bioportfolio.com/indepth/Louping_Ill.pdf...

King Pharmaceuticals
16:50 ET, King Pharmaceuticals Provides Details for Live Webcast and Conference Call Following Release of Fourth Quarter 2005 Earnings. Feb 21, 06 ...
http://www.prnewswire.com/gh/cnoc/comp/120319.html...

News Archive - 2006 | Wyeth.com
Wyeth Sets Webcast and Conference Call for 2006 Third Quarter Earnings ... King Pharmaceuticals and Wyeth Announce Restructuring of Co-Promotion Agreement ...
http://www.wyeth.com/news/archive?nav=archieve&navTo=2006...

Google Custom Search

Search
  

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.